PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
Boulder Peptide

Press Release


Receive press releases from Boulder Peptide: By Email RSS Feeds:

Boulder Peptide Announces New SAB and 2014 Meeting


Boulder, CO, November 23, 2013 --(PR.com)-- The Boulder Peptide Symposium will host its 8th Annual meeting in late September 2014. In preparation, the symposium board of trustees has assembled an esteemed Scientific Advisory Board to foster the event. The SAB brings together experts from industry and academia with a significant body of experience in discovery and development of peptide therapeutics.

John Carpenter, Ph.D. Professor of Pharmaceutical Sciences and Co-Director of the Center for Pharmaceutical Biotechnology, University of Colorado, Anschutz Medical Campus, Denver
Waleed Danho, Ph.D. Consultant, formerly Distinguished Research Leader, Hoffmann La Roche
Phil Dawson, Ph.D. Associate Professor & Associate Dean of Graduate Studies, The Scripps Research Institute, La Jolla
Nader Fotouhi, Ph.D. Vice President, Pharma Research and Early Development Site Leader, Hoffmann La Roche, Nutley
Tomas Landh, Ph.D. Director of Strategy and Innovation Sourcing, Novo Nordisk, Denmark
Barbara Lueckel, Ph.D. Global Business Development Director, F. Hoffman-La Roche Ltd., Basel
John Mayer, Ph.D. Senior Research Scientist, University of Indiana
Chris Rhodes, Ph.D. Consultant in Pharmaceutical Technology, formerly Executive Director, Pharmaceutical R&D, Amylin Pharmaceuticals
Tomi Sawyer, Ph.D. Entrepreneurial Drug Hunter, Adjunct Professor, University of Massachusetts and UMass Medical School, formerly Chief Scientific Officer, Aileron Therapeutics
Ved Srivastava, Ph.D. Head, Peptide Chemistry, GlaxoSmithKline
Elizabeth Topp, Ph.D. Dane O. Kildsig Chair and Head of the Department of Industrial and Physical Pharmacy, Purdue University

Each year, the Boulder Peptide Symposium is organized around a theme. The SAB has designed a meeting for 2014 that will be focused broadly on peptides in infectious disease, including anti-virals, anti-microbials, and neglected diseases. Special emphasis will be given to platform technologies designed to create constrained peptide structures with improved properties.

The Boulder Peptide Symposium is a nonprofit organization. More information about the mission and the annual meeting can be found on the website at www.boulderpeptide.org.

The 8th Annual meeting will take place at the St. Julien Hotel and Spa in Boulder Colorado on Sept 22 to 24, 2014.

The Boulder Peptide Symposium Board of Trustees – a non-profit organization.
Contact Information
Boulder Peptide
Ralph Dilibero
720 318 2339
Contact
www.boulderpeptide.org

Click here to view the list of recent Press Releases from Boulder Peptide
Promote Your Business